OSI acquires Eyetech.
|
DEALS |
|||
|
WHO |
WITH |
WHAT |
SCOOP |
|
OSI Pharmaceuticals |
Eyetech Pharmaceuticals |
$935M acquisition |
OSI will gain Macugen, a drug developed for the wet version of macular degeneration. |
|
Cardiome Pharma |
Artesian Therapeutics |
Acquisition with up to $32M in milestone payments |
Cardiome will gain two advanced small molecule discovery programs in congestive heart failure. |
|
Biovitrum |
Arexis |
Acquisition |
Arexis is entering the clinic with experimental drugs for diabetes. |